Ziyaad Waja

835 total citations
22 papers, 182 citations indexed

About

Ziyaad Waja is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Ziyaad Waja has authored 22 papers receiving a total of 182 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 11 papers in Epidemiology and 4 papers in Virology. Recurrent topics in Ziyaad Waja's work include Tuberculosis Research and Epidemiology (13 papers), Mycobacterium research and diagnosis (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). Ziyaad Waja is often cited by papers focused on Tuberculosis Research and Epidemiology (13 papers), Mycobacterium research and diagnosis (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). Ziyaad Waja collaborates with scholars based in South Africa, United States and Australia. Ziyaad Waja's co-authors include Neil Martinson, Richard E. Chaisson, Kelly E. Dooley, Christopher J. Hoffmann, Nicole Salazar‐Austin, Bavesh D Kana, Bhavna G. Gordhan, Silvia Cohn, Sanjay G. Lala and Jennifer Hoffmann and has published in prestigious journals such as Clinical Infectious Diseases, Scientific Reports and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Ziyaad Waja

17 papers receiving 180 citations

Peers

Countries citing papers authored by Ziyaad Waja

Since Specialization

Citations

This map shows the geographic impact of Ziyaad Waja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziyaad Waja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziyaad Waja more than expected).

Fields of papers citing papers by Ziyaad Waja

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziyaad Waja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziyaad Waja. The network helps show where Ziyaad Waja may publish in the future.

Co-authorship network of co-authors of Ziyaad Waja

This figure shows the co-authorship network connecting the top 25 collaborators of Ziyaad Waja. A scholar is included among the top collaborators of Ziyaad Waja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziyaad Waja. Ziyaad Waja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluating smoking cessation interventions for people living with HIV in a factorial randomised clinical trial in South Africa using the Multiphase Optimization Strategy (MOST) framework: The Tlogela Trial protocol 2025 ·Contemporary Clinical Trials ·(unknown), (unknown), (unknown), Raymond Niaura, Bareng A. S. Nonyane, Christopher J. Hoffmann, Hojoon Sohn, Christopher G. Kemp, Kate Guastaferro, (unknown), (unknown), Ziyaad Waja, Neil Martinson, Jonathan E. Golub, Jessica L. Elf	0
2	Assessing TB treatment outcomes in pregnant women living with HIV with drug-susceptible TB 2025 ·Public Health Action ·(unknown), Sylvia Cohn, Ziyaad Waja, Richard E. Chaisson, Neil Martinson, Nicole Salazar‐Austin	1
3	Prolonged Diagnostic Interval Leads to High Lymphoma Related Mortality in a Prospective Cohort of People with HIV Undergoing Fine Needle Aspiration 2025 ·Cancers ·(unknown), Khuthadzo Hlongwane, (unknown), (unknown), (unknown), Rebecca Berhanu, Ziyaad Waja, Wendy Stevens, Tanvier Omar, Neil Martinson, Richard F. Ambinder, Rena R. Xian	0
4	Incidence and associated risk factors of anti-tuberculosis drug induced liver injury among TB patients 2025 ·BMC Infectious Diseases ·(unknown), Ziyaad Waja, Roslyn Thelingwani, (unknown), (unknown), (unknown), Tom Boyles, (unknown), Ananyo Choudhury, (unknown), (unknown)	0
5	Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes 2025 ·Emerging infectious diseases ·Ekaterina V. Kurbatova, William C. Whitworth, (unknown), Patrick Phillips, Nigel Scott, Kia Bryant, Rodney Dawson, Sandra Wagner Cardoso, Wadzanai Samaneka, Melissa Engle, Ziyaad Waja, Erin Sizemore, Wendy Carr, Kelly E. Dooley, Radojka M. Savić, Susan Swindells, Richard E. Chaisson, Susan E. Dorman, Payam Nahid, Nguyen Viet Nhung	0
6	Innate immune dysfunction and persistent activation in South African HIV elite controllers 2025 ·Frontiers in Immunology ·(unknown), (unknown), Sharon Shalekoff, (unknown), Ziyaad Waja, Neil Martinson, Caroline T. Tiemessen, Christina Thobakgale	0
7	Real-world treatment outcomes for Hodgkin lymphoma in South Africa: a prospective observational study 2024 ·Infectious Agents and Cancer ·(unknown), (unknown), Marianna Zahurak, (unknown), (unknown), (unknown), Ziyaad Waja, (unknown), Tanvier Omar, Wendy Stevens, (unknown), Kennedy Otwombe, Khuthadzo Hlongwane, Ravi Varadhan, Moosa Patel, Richard F. Ambinder, Neil Martinson, Rena R. Xian, (unknown)	2
8	Clinical Strains of Mycobacterium tuberculosis Representing Different Genotype Families Exhibit Distinct Propensities to Adopt the Differentially Culturable State 2024 ·Pathogens ·Bhavna G. Gordhan, (unknown), (unknown), (unknown), Michael S. VanNieuwenhze, Ziyaad Waja, Neil Martinson, Bavesh D Kana	1
9	Differentially culturable tubercle bacteria as a measure of tuberculosis treatment response 2023 ·Frontiers in Cellular and Infection Microbiology ·(unknown), (unknown), (unknown), (unknown), Bhavna G. Gordhan, Ziyaad Waja, Kennedy Otwombe, (unknown), Mireille Kamariza, Timothy R. Sterling, Carolyn R. Bertozzi, Neil Martinson, Bavesh D Kana	10
10	SMA-TB: study protocol for the phase 2b randomized double-blind, placebo-controlled trial to estimate the potential efficacy and safety of two repurposed drugs, acetylsalicylic acid and ibuprofen, for use as adjunct therapy added to, and compared with, the standard WHO recommended TB regimen 2023 ·Trials ·(unknown), Kennedy Otwombe, Ziyaad Waja, Nestani Tukvadze, (unknown), (unknown), Kaori L. Fonseca, (unknown), (unknown), Dan Ouchi, (unknown), (unknown), Carles Quiñones, Sergo Vashakidze, Neil Martinson, Cristina Vilaplana	3
11	The performance of tongue swabs for detection of pulmonary tuberculosis 2023 ·Frontiers in Cellular and Infection Microbiology ·Christopher Ealand, (unknown), (unknown), Bhavna G. Gordhan, Mireille Kamariza, Carolyn R. Bertozzi, Ziyaad Waja, Neil Martinson, Bavesh D Kana	8
12	Detection of differentially culturable tubercle bacteria in sputum using mycobacterial culture filtrates 2021 ·Scientific Reports ·Bhavna G. Gordhan, (unknown), (unknown), Edith E. Machowski, Christopher Ealand, Ziyaad Waja, Neil Martinson, Bavesh D Kana	25
13	Supplementation of sputum cultures with culture filtrate to detect tuberculosis in a cross-sectional study of HIV-infected individuals 2021 ·Tuberculosis ·(unknown), Bhavna G. Gordhan, Ziyaad Waja, Kennedy Otwombe, Neil Martinson, Bavesh D Kana	9
14	Comparing rates of mycobacterial clearance in sputum smear-negative and smear-positive adults living with HIV 2021 ·BMC Infectious Diseases ·Edith E. Machowski, (unknown), Limakatso Lebina, Ziyaad Waja, Reginah Msandiwa, Minja Milovanovic, Bhavna G. Gordhan, Kennedy Otwombe, Sven O. Friedrich, Richard E. Chaisson, Andreas H. Diacon, Bavesh D Kana, Neil Martinson	1
15	Performance of the Roche cobas MTB Assay for the Molecular Diagnosis of Pulmonary Tuberculosis in a High HIV Burden Setting 2020 ·Journal of Molecular Diagnostics ·Lesley Scott, Anura David, (unknown), (unknown), (unknown), Ziyaad Waja, Neil Martinson, (unknown), Elizabeth M. Marlowe, Wendy Stevens	11
16	Subclinical tuberculosis and adverse infant outcomes in pregnant women with HIV 2020 ·The International Journal of Tuberculosis and Lung Disease ·Hannah M. Rickman, Sylvia Cohn, (unknown), Ziyaad Waja, Nicole Salazar‐Austin, Jennifer Hoffmann, Kelly E. Dooley, Christopher J. Hoffmann, Richard E. Chaisson, Neil Martinson, (unknown)	7
17	Human leukocyte antigen associations with protection against tuberculosis infection and disease in human immunodeficiency virus-1 infected individuals, despite household tuberculosis exposure and immune suppression 2020 ·Tuberculosis ·(unknown), Ian James, Shayne Loubser, Ziyaad Waja, S. Mallal, Christopher J. Hoffmann, Caroline T. Tiemessen, Richard E. Chaisson, Neil Martinson	7
18	Population Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Pregnant South African Women with Tuberculosis and HIV 2019 ·Antimicrobial Agents and Chemotherapy ·(unknown), Rory Leisegang, Kelly E. Dooley, Jyoti S. Mathad, Lubbe Wiesner, Helen McIlleron, Neil Martinson, Ziyaad Waja, (unknown), Richard E. Chaisson, Paolo Denti	25
19	Chronic HIV-1 Infection Alters the Cellular Distribution of FcγRIIIa and the Functional Consequence of the FcγRIIIa-F158V Variant 2019 ·Frontiers in Immunology ·(unknown), Ria Lassaunière, Bianca Da Costa Dias, Ziyaad Waja, Neil Martinson, Caroline T. Tiemessen	2
20	Isoniazid Preventive Therapy and Pregnancy Outcomes in Women Living With Human Immunodeficiency Virus in the Tshepiso Cohort 2019 ·Clinical Infectious Diseases ·Nicole Salazar‐Austin, Silvia Cohn, Sanjay G. Lala, Ziyaad Waja, Kelly E. Dooley, Christopher J. Hoffmann, Richard E. Chaisson, Neil Martinson	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact